Normal function · from ai-gene-review (O95255, commit 79fe13b38970) · AI-generated, not KB evidence

ABCC6 (MRP6) is an ATP-dependent organic-anion transporter expressed prominently at the basolateral membrane of hepatocytes. Human ABCC6 transports glutathione conjugates, including leukotriene C4, in membrane assays. Its principal physiological role is to support extracellular nucleotide release and inhibit ectopic mineralization. Released ATP is converted by ENPP1 to AMP and inorganic pyrophosphate (PPi), an inhibitor of calcium-phosphate crystal growth. Direct ATP passage through ABCC6 and the principal endogenous transported substrate remain unresolved. ABCC6 deficiency lowers circulating PPi, while local cellular pathways also influence mineralization. Biallelic pathogenic variants cause pseudoxanthoma elasticum and can cause generalized arterial calcification of infancy, affecting skin, eyes and arteries. The short alternative product URG7 has a distinct ER-membrane location and is not equivalent to the full-length transporter.

ATP-dependent organic-anion export by a basolateral ABC transporter. Glutathione conjugates are demonstrated assay substrates; the main endogenous cargo remains unresolved. ABCC6-dependent nucleotide release contributes to extracellular PPi production and prevention of ectopic mineralization, without proving direct ATP translocation.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Arterial Calcification of Infancy causative germline
mechanism: Extracellular pyrophosphate anti-mineralization failure
subtype: ABCC6-related
scoped to subtype: ABCC6-related
Pseudoxanthoma Elasticum causative germline loss of function
mechanism: ABCC6 Transporter Loss of Function
subtype: AR PXE; PXE forme fruste
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
inherited pseudoxanthoma elasticum MONDO:0100091 SD Definitive
2025-10-22

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.